EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Asia Pacific

World Mosquito Program to roll out in Sri Lanka

The agreement advances the partnership between Sri Lanka and the WMP in tackling the threat of mosquito borne-viruses such as dengue in Sri Lanka.     Mona...
Continue Reading →
Europe

Medicalchain to present to Mayo Clinic

Robert Miller to talk about blockchain, healthcare, and ICOs. Robert Miller, Director of Business Development at Medicalchain, will be presenting to Mayo Clinic on Mo...
Continue Reading →
Europe

SBRI Healthcare backs high potential cancer screening technologies

£1 million awarded to develop innovations for earlier and faster diagnosis Cancer survival rates in England are at an all-time high with over 7000 more people survivi...
Continue Reading →
Europe

Metrion Biosciences establishes Scientific Advisory Board

SAB will provide scientific oversight and strategic advice to support Metrion’s ion channel screening, cardiac safety testing, and native tissue and human stem cell t...
Continue Reading →
Europe

Nosopharm receives €1 million loan from Bpifrance

Funding for preclinical research with the view to applying for clinical trial authorisation for first drug candidate in new class of antibiotics Nosopharm, a company ...
Continue Reading →
news

Sanofi, DNDi seek EMA review for sleeping sickness treatment

Fexinidazole would be first all-oral treatment under investigation for both first and second stages of sleeping sickness, a fatal disease, endemic in Africa. Sanofi h...
Continue Reading →
news

Cmed to showcase own eSource technology at SCOPE 2018

Cmed, an innovative technology-led CRO, will demonstrate the eSource and live data analytics capabilities of encapsia®, a next generation clinical data suite, at Summ...
Continue Reading →
news

ERT Expands Respiratory Services to Support New Endpoints

Industry-leading MasterScope™ integrates with centralized Forced Oscillation Technique service to deliver high quality data while lessening patient and site burden  E...
Continue Reading →
Europe

GamaMabs Pharma receives Orphan Drug Designation from US FDA for lead compound GM102

This designation has been awarded for the treatment of AMHR2-expressing ovarian cancers, exclusive of AMHR2-expressing fallopian tube cancers and primary peritoneal c...
Continue Reading →
news

Symcel expands staff for clinical market growth and Horizon 2020 funded validation of antimicrobial susceptibility testing

calScreener™ to become the industry gold standard for combination testing of antibiotics within five years Symcel – the company behind the revolutionary cell-based as...
Continue Reading →
Quotient